MedPath

The role of testosterone in value-based decision making

Completed
Conditions
Psychological disorders characterized by abnormal decision-making (such as drug abuse, gambling, (social) fear disorders, heightened BMI, psychopathology, antisocial personality disorders, etc.)
Registration Number
NL-OMON24462
Lead Sponsor
Prof. dr. Karin Roelofs (Behavioral Science Institute (BSI) & Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen)
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

Healthy female volunteers between 18 and 35 years of age

- Use of single-phase oral contraception with testing only during the 3-week period they take these contraceptives, and not during menstruation (to control for the possible effect of hormonal changes related to the menstrual cycle)

Exclusion Criteria

- Abnormal hearing

- Abnormal and uncorrected vision

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- Behavioral performance on computerized tasks assessing choice behavior and their underlying psychological mechanisms in contexts including risky choice, intertemporal choice, and reward-history and social learning in reinforcement-based decision making
Secondary Outcome Measures
NameTimeMethod
- Salivary cortisol and testosterone hormone levels<br /><br>- Subjective measurements on self-report questionnaires<br>
© Copyright 2025. All Rights Reserved by MedPath